ResMed Inc (RMD)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
$243.00
Buy
$249.70
$-1.40 (-0.57%)
Prices updated at 18 Dec 2025, 00:21 EST
| Prices minimum 15 mins delay
Prices in USD
ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 4,685m | 5,146m | |
| 2,655m | 3,055m | |
| 1,384m | 1,687m | |
| 29.54 | 32.79 | |
| 1,021m | 1,401m | |
| 1,600m | 1,923m | |
| Sales, General and administrative | 917m | 991m |
| Interest expenses | - | - |
| Provision for income taxes | 244m | 277m |
| Operating expenses | 1,271m | 1,368m |
| Income before taxes | 1,265m | 1,678m |
| Net income available to common shareholders | 1,021m | 1,401m |
| 8.5 | 9.81 | |
| Net interest income | -46m | 4m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 8.47 | 9.77 |
| Free cash flow per share | 9.1268 | 11.936 |
| Book value/share | 35.3749 | 41.9361 |
| Debt equity ratio | 0.17244 | 0.135963 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 2,358m | 3,506m |
| Current liabilities | 911m | 1,019m |
| Total capital | 5,561m | 6,626m |
| Total debt | 874m | 852m |
| Total equity | 4,864m | 5,968m |
| Total non current liabilities | - | - |
| Loans | 697m | 658m |
| Total assets | 6,872m | 8,174m |
| Total liabilities | - | - |
| Cash and cash equivalents | 238m | 1,209m |
| Common stock | 147m | 146m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 228m | 238m |
| Cash dividends paid | -282m | -311m |
| 1,286m | 1,651m | |
| Investments (gains) losses | -270m | -200m |
| 238m | 1,209m | |
| Net income | - | - |
| 1,401m | 1,752m | |
| -115m | -101m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.